Matches in Nanopublications for { ?s ?p "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP210422.RAxRUQO4SLjoCCiBqaja9TwLSBeqihAixLiA0LvNPxexw130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210422.RAxRUQO4SLjoCCiBqaja9TwLSBeqihAixLiA0LvNPxexw130_provenance.
- NP321381.RAwqYCHMq-jQCxTnOIr2L1jFfc2iW0KgBZdjMLfTUGp9s130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321381.RAwqYCHMq-jQCxTnOIr2L1jFfc2iW0KgBZdjMLfTUGp9s130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP752337.RAw9CdEu_rX0LhpauYXjKunFUMXLXOd-LZxUtNwcjwb_0130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752337.RAw9CdEu_rX0LhpauYXjKunFUMXLXOd-LZxUtNwcjwb_0130_provenance.
- NP882141.RA3J_YJVVrnG0y9BxOhGEjLpd5CJ3BJTeFFMJ1AvgfXko130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882141.RA3J_YJVVrnG0y9BxOhGEjLpd5CJ3BJTeFFMJ1AvgfXko130_provenance.
- NP852439.RAzt9lT8xr-xvNHZU9IhBZDBHNE6tEpWoHObQlRbxQab0130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852439.RAzt9lT8xr-xvNHZU9IhBZDBHNE6tEpWoHObQlRbxQab0130_provenance.
- NP926731.RAJdJSd71wMGn9PQa6JAgC5_z70IOMPAQrokEK0BkkEBM130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926731.RAJdJSd71wMGn9PQa6JAgC5_z70IOMPAQrokEK0BkkEBM130_provenance.
- NP914633.RALSvAlRRij16W7_wloerTt9jALfhadMdsTSJNwigg4rc130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914633.RALSvAlRRij16W7_wloerTt9jALfhadMdsTSJNwigg4rc130_provenance.